Abuse of anabolic-androgenic steroids and bodybuilding acne: An underestimated health problem [Anabolikamissbrauch und bodybuilding-akne: Eine unterschätzte gesundheitliche gefährdung]
| Autor(en): | Melnik, B. Jansen, T. Grabbe, S. |
Stichwörter: | 3(or 17)beta hydroxysteroid dehydrogenase, 9015-81-0; delta12 prostaglandin J2, 87893-54-7; diacylglycerol acyltransferase, 9029-98-5; isotretinoin, 4759-48-2; mesterolone, 1424-00-6; metandienone, 72-63-9; metenolone, 153-00-4; metenolone acetate, 434-05-9; methandriol, 521-10-8; methyltestosterone, 58-18-4; nandrolone, 434-22-0; nandrolone decanoate, 360-70-3; oxandrolone, 53-39-4; peroxisome proliferator activated receptor alpha, 147258-70-6; prasterone, 53-43-0; squalene, 111-02-4, 7683-64-9; stanozolol, 10418-03-8, 302-96-5; testosterone, 58-22-0; testosterone enantate, 315-37-7; zileuton, 111406-87-2, 132880-11-6; Anabolic Agents; Androgens; Steroids; 3(or 17)beta hydroxysteroid dehydrogenase; acne conglobata; acne fulminans; Adolescent; Adult; aggression; anabolic agent; Anabolic Agents; Anabolic-androgenic steroids; Anabolics; androgen; Androgens; athlete; body building; Bodybuilding acne; cardiotoxicity; delta12 prostaglandin J2; depression; diacylglycerol acyltransferase; differential diagnosis; doping; Doping acne; Doping in Sports; drug abuse pattern; drug misuse; edema; erectile dysfunction; fatty acid; fear; gynecomastia; hair growth; headache; Health risk; human; Humans; illicit drug; impotence; isotretinoin; libido disorder; Male; mesterolone; metandienone; metenolone; metenolone acetate; methandriol; methyltestosterone; mood change; Muscle, Skeletal; nandrolone; nandrolone decanoate; omnadren; oxandrolone; oxitosona; pathophysiology; peroxisome proliferator activated receptor alpha; peroxisome proliferator activated receptor gamma; Physical Fitness; Physician-Patient Relations; prasterone; retinoid; review; sex hormone binding globulin; sleep disorder; Somatotypes; squalene; stanozolol; steroid 5alpha reductase; Steroids; Substance-Related Disorders; sudden death; systanon; testis atrophy; testis weight; testosterone; testosterone enantate; triacylglycerol; unclassified drug; urinalysis; water retention, Acne Vulgaris; World Health; zileuton, acne | Erscheinungsdatum: | 2007 | Journal: | JDDG - Journal of the German Society of Dermatology | Volumen: | 5 | Ausgabe: | 2 | Startseite: | 110 | Seitenende: | 117 | Zusammenfassung: | Abuse of anabolic-androgenic steroids (AAS) by members of fitness centers and others in Germany has reached alarming dimensions. The health care system provides the illegal AAS to 48.1 % of abusers. Physicians are involved in illegal prescription of AAS and monitoring of 32.1 % of AAS abusers. Besides health-threatening cardiovascular, hepatotoxic and psychiatric long-term side effects of AAS, acne occurs in about 50 % of AAS abusers and is an important clinical indicator of AAS abuse, especially in young men 18-26 years of age. Both acne conglobata and acne fulminans can be induced by AAS abuse. The dermatologist should recognize bodybuilding acne, address the AAS abuse, and warn the patient about other potential hazards. © 2007 The Authors. |
ISSN: | 16100379 | DOI: | 10.1111/j.1610-0387.2007.06176.x | Externe URL: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-33846849515&doi=10.1111%2fj.1610-0387.2007.06176.x&partnerID=40&md5=dba7656b5366077301c3585efd3a3c27 |
Show full item record
